Bullish Case: ILMN’s 124% one-year and 48.6% 90-day gains, 69% call-volume premium, and 5% bullish-risk advantage show strong momentum. Recent 8% organic growth excluding China, the China-localized MiSeq launch, and a settled Grail lawsuit reduce some overhang. Helium’s price-density peaks near $220–230, while its IV is below market IV across listed maturities, consistent with less incremental uncertainty.

Bearish Case: The rally is extended: ILMN is up 18.6% in a week and trades near the $220–230 density cluster, increasing mean-reversion risk. Implied volatility remains elevated—roughly 40–49% in Helium’s near-to-long maturities and 46–52% in market data—with pronounced downside-skew indications from deep puts. Valuation, insider selling, China restrictions, competition, and upcoming refinancing/court dates could amplify a reversal.

Potential Outcomes:

1. 45%: consolidates at $205–235; falsified by a sustained close outside that range.
2. 25%: momentum extends to $240–260 on strong guidance or adoption; falsified below $205.
3. 22%: correction to $175–205 as mean reversion or weak execution dominates; falsified if $235 holds.
4. 8%: catalyst shock below $175 or above $260 around earnings, Sep. 9 debt repayment, Sep. 18 expiry, or November court approval.

Helium’s historical-return surface supports reversion, while its price-density graph centers near $220–230. Prior downside calls failed; the recent bullish range call was directionally better but underpredicted magnitude.

August 25, 2026